Pfizer (PFE) Announces Top-Line Results Of Prevenar 13 Phase 3 Trial
Go back to Pfizer (PFE) Announces Top-Line Results Of Prevenar 13 Phase 3 Trial| Pfizer Inc. (NYSE: PFE) | Delayed: 28.28 +0.46 (1.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.82 | 52 Week High | $37.39 | |||
| Open | $27.61 | 52 Week Low | $28.25 | |||
| Day High | $28.29 | P/E | 17.14 | |||
| Day Low | $27.59 | EPS | $1.65 | |||
| Volume | 23,203,230 | |||||



